全文获取类型
收费全文 | 477篇 |
免费 | 32篇 |
国内免费 | 10篇 |
专业分类
儿科学 | 31篇 |
基础医学 | 20篇 |
临床医学 | 77篇 |
内科学 | 235篇 |
神经病学 | 5篇 |
特种医学 | 12篇 |
外科学 | 6篇 |
综合类 | 56篇 |
预防医学 | 3篇 |
药学 | 45篇 |
1篇 | |
中国医学 | 8篇 |
肿瘤学 | 20篇 |
出版年
2023年 | 10篇 |
2022年 | 8篇 |
2021年 | 12篇 |
2020年 | 21篇 |
2019年 | 18篇 |
2018年 | 16篇 |
2017年 | 16篇 |
2016年 | 24篇 |
2015年 | 8篇 |
2014年 | 27篇 |
2013年 | 34篇 |
2012年 | 24篇 |
2011年 | 21篇 |
2010年 | 15篇 |
2009年 | 13篇 |
2008年 | 24篇 |
2007年 | 14篇 |
2006年 | 16篇 |
2005年 | 16篇 |
2004年 | 19篇 |
2003年 | 7篇 |
2002年 | 10篇 |
2001年 | 28篇 |
2000年 | 22篇 |
1999年 | 27篇 |
1998年 | 23篇 |
1997年 | 20篇 |
1996年 | 14篇 |
1995年 | 4篇 |
1982年 | 1篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1972年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有519条查询结果,搜索用时 15 毫秒
1.
病毒性肝炎患者血小板减少与脾脏肿大和血小板生成素的关系 总被引:1,自引:0,他引:1
目的研究病毒性肝炎患者血小板减少、脾脏肿大及血清血小板生成素(TPO)水平之间的关系,以探讨病毒性肝炎患者血小板减少的发病机制。方法应用腹部彩色B超测量58例病毒性肝炎并血小板减少症患者(A组)以及48例病毒性肝炎血小板正常患者(B组)和20例健康志愿者(C组)的脾脏大小,并采用酶联免疫吸附法测定其血清TPO水平。结果A组脾脏厚度(50.49±13.58mm)明显大于B组(38.45±8.14mm,P<0.01)和C组(32.25±3.73mm,P<0.01)。血小板数与脾脏大小呈负相关(r=-0.553,P<0.01)。血清TPO水平A组(88.05±17.09pg/mL)明显低于B组(100.20±17.63pg/mL,P<0.01)和C组(108.96±25.90pg/mL,P<0.01)。血小板数与血清TPO水平呈正相关(r=0.407,P<0.01)。结论病毒性肝炎血小板减少与脾脏肿大、血清TPO水平下降有关。 相似文献
2.
3.
4.
Seong-Keun Cho Jae-Hwan Kim Jong-Yi Park Yun-Jung Choi Jae-Il Bang Kyu-Chan Hwang Eun-Jeong Cho Sea-Hwan Sohn Sang Jun Uhm Deog-Bon Koo Kyung-Kwang Lee Teoan Kim Jin-Hoi Kim 《Developmental dynamics》2007,236(12):3369-3382
Somatic cell nuclear transfer (scNT) is a useful way to create cloned animals. However, scNT clones exhibit high levels of phenotypic instability. This instability may be due to epigenetic reprogramming and/or genomic damage in the donor cells. To test this, we produced transgenic pig fibroblasts harboring the truncated human thrombopoietin (hTPO) gene and used them as donor cells in scNT to produce first-generation (G1) cloned piglets. In this study, 2,818 scNT embryos were transferred to 11 recipients and five G1 piglets were obtained. Among them, a clone had a dimorphic facial appearance with severe hypertelorism and a broad prominent nasal bridge. The other clones looked normal. Second-generation (G2) scNT piglets were then produced using ear cells from a G1 piglet that had an abnormal nose phenotype. We reasoned that, if the phenotypic abnormality of the G1 clone was not present in the G2 and third-generation (G3) clones, or was absent in the G2 clones but reappeared in the G3 clones, the phenotypic instability of the G1 clone could be attributed to faulty epigenetic reprogramming rather than to inherent/accidental genomic damage to the donor cells. Blastocyst rates, cell numbers in blastocyst, pregnancy rates, term placenta weight and ponderal index, and birth weight between G1 and G2 clones did not differ, but were significantly (P < 0.05) lower than control age- and sex-matched piglets. Next, we analyzed global methylation changes during development of the preimplantation embryos reconstructed by donor cells used for the production of G1 and G2 clones and could not find any significant differences in the methylation patterns between G1 and G2 clones. Indeed, we failed to detect the phenotypic abnormality in the G2 and G3 clones. Thus, the phenotypic abnormality of the G1 clone is likely to be due to epigenetic dysregulation. Additional observations then suggested that expression of the hTPO gene in the transgenic clones did not appear to be the cause of the phenotypic abnormality in the G1 clones and that the abnormality was acquired by only a few of the G1 clone's cells during its gestational development. 相似文献
5.
Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders 总被引:2,自引:0,他引:2
The thrombopoietin receptor (Mpl) is involved in the pathogenesis of chronic myeloproliferative disorders (CMPD). In this study, we determined Mpl expression by bone marrow cells and megakaryocytes in CMPD by applying laser microdissection, real-time RT-PCR, and immunohistochemistry. Mpl mRNA expression was significantly increased up to 9-fold in total bone marrow cells (p < 0.001) and up to 4-fold in megakaryocytes in chronic myeloproliferative disorders (n = 73) compared to normal controls (n = 26, p = 0.01). Immunohistochemistry revealed heterogeneous Mpl expression by megakaryocytes in CMPD with a stronger accentuation in idiopathic myelofibrosis (IMF) in comparison to polycythaemia vera (PV) and essential thrombocythemia (ET). In addition to megakaryocytes, the erythropoietic lineage was prominently labelled by Mpl antiserum, with considerably stronger staining in polycythaemia vera. We conclude that, in CMPD, megakaryocytes and erythroid cells exhibit increased Mpl expression levels which may contribute to the sustained proliferation of both cell lineages in CMPD. 相似文献
6.
Isolation of endothelial progenitor cells from cord blood and induction of differentiation by ex vivo expansion 总被引:4,自引:0,他引:4
Endothelial progenitor cells (EPCs) have been reported to possess the capacity to colonize vascular grafts and hold promise for therapeutic neovascularization. However, limited quantities of EPCs have been the major factor impeding effective research on vasculoangiogenesis. In this study, cytokine and culture conditions necessary for the provision of large quantities of endothelial cells (ECs) were investigated. Cord blood was collected from 18 normal full-term deliveries and CD34+ cells were isolated by MACS system (Miltenyi Biotech, Bergish-Gladbach, Germany). To evaluate the effect of cytokines, CD34+ cells were cultured with various cytokine combinations, such as stem cell factor (SCF), flt3-ligand (FL), and thrombopoietin (TPO) with vascular endothelial growth factor (VEGF), interleukin-1 beta , fibroblast growth factor-basic (FGF-b) as basic cytokines. The quantities of non-adherent and adherent cells were the greatest with SCF, FL and TPO. The addition of TPO to all other cytokines significantly increased the number of non-adherent and adherent cells (p< 0.05, Wilcoxon rank sum test). After four weeks of culture, adherent cells expressed endothelial specific markers such as KDR, CD31 and CD62E. Typical morphology of ECs was observed during culture, such as cord-like structure and cobblestone appearance, suggesting that the adherent cells were consistent with ECs. In this study, the experimental conditions that optimize the production of ECs for therapeutic neovascularization were described. And it was possibly suggested that TPO plays a major role in differentiation from EPCs to ECs. 相似文献
7.
Elena V. Suntsova Alexey A. Maschan Dina D. Baydildina Irina I. Kalinina Uliana N. Petrova Alexey V. Pshonkin Galina A. Novichkova 《Pediatric blood & cancer》2019,66(6)
We retrospectively analyzed sequential therapy with romiplostim and eltrombopag in 23 children with immune thrombocytopenia: switching from romiplostim to eltrombopag (10 patients) or vice versa (13 patients). The median age of patients at enrollment in the study was 5.6 years (2‐15 years). Switching from romiplostim to eltrombopag was effective in eight (80%) patients, whereas switching from eltrombopag to romiplostim was effective in eight (62%) patients. The response rate was similar in patients failing the first thrombopoietin receptor agonist and those who had previous response. To date, all responders continue to maintain platelets over 50 × 109/L at 13‐39 months after switching. 相似文献
8.
Serum and intracytoplasmic cytokines are mandatory in host defense against microbes, but also play a pivotal role in the pathogenesis of autoimmune diseases by initiating and perpetuating various cellular and humoral autoimmune processes. 相似文献
9.
10.
Ishiguro A Suzuki Y Mito M Shimbo T Matsubara K Kato T Miyazaki H 《British journal of haematology》2002,116(3):612-618
To clarify the mechanisms underlying thrombocytosis secondary to infections, we longitudinally studied serum levels of thrombopoietin (TPO) and interleukin (IL)-6 in 15 infants and young children with prominent thrombocytosis (platelets >700 x 10(9)/l) following acute infections and 116 age-matched controls using an enzyme-linked immunosorbent assay. The subjects included nine patients with bacterial infections, three with viral infections and three with non-determined pathogens. TPO values in the controls were 2.24 +/- 0.87 fmol/ml (mean +/- SD) with a 95% reference interval of 0.85-4.47 fmol/ml. In the first week of infection, platelet counts were normal, but TPO values increased (approximately 10.73 fmol/ml). TPO levels peaked on day 4 +/- 2 at 6.44 +/- 2.37 fmol/ml and then fell gradually. When platelet counts peaked in the second and third weeks, TPO levels were similar to the controls. IL-6 levels in the first week rose and dropped more rapidly than TPO. Serum TPO values were significantly correlated with C-reactive protein levels (r = 0.688, P < 0.001) and IL-6 levels (r = 0.481, P = 0.027). These results suggest that TPO contributes to thrombocytosis following infections in conjunction with IL-6, arguing for additional regulatory mechanisms of blood TPO levels. 相似文献